About
Paul Terence Kohler, Jr. ('Terry') has served as Chief Financial Officer and Treasurer since February 26, 2026, after joining ADMA in December 2025 as Executive Financial Advisor. He previously was Chief Financial Officer of OptiNose from October 2024 through its acquisition in May 2025 and CFO of Verrica Pharmaceuticals from July 2021 to October 2024, and earlier held corporate development and treasury roles at Endo International. He holds a B.A. from Dickinson College and an M.B.A. from the University of North Carolina and is a Certified Management Accountant.
Roles
Adma Biologics, Inc.
Chief Financial Officer and Treasurer · Current role
2025–present
OptiNose, Inc.
Chief Financial Officer · Served as CFO through the company's acquisition in May 2025.
October 2024-May 2025
Verrica Pharmaceuticals Inc.
Chief Financial Officer · Supported commercial launch preparations for a topical molluscum contagiosum treatment and R&D pipeline investments.
July 2021-October 2024
Endo International PLC
Vice President - Corporate Development and Treasurer
March 2020-July 2021
Fixed Compensation
FY 2025
All other compensation
$11,992
Performance Compensation
Data from FY 2025
Cash incentive
Discretionary bonus
$15,750
Stock awards
Stock awards (RSUs)
$1,124,988
Also at Adma Biologics, Inc.